Eyenovia has received Notices of Allowance from the U.S. Patent and Trademark Office for two patent applications providing coverage on physiologic microdroplet ejection diameters and velocities, according to a press release.
Once the new patents are issued, Eyenovia will hold eight U.S. patents and 27 issued and allowed international patents in micro-therapeutic ophthalmic delivery.
“We are pleased that the USPTO continues to recognize the novel features of our piezo-print technology that has the ability to gently and efficiently deliver micro-therapeutic solutions to the eye,” Sean
Uncategorized